CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL)
@CRL.asset
$118.46
At close:
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
Figures
- Sector Healthcare
- Industry Medical Diagnostics & Research
- Index S&P 500
- Market Cap $6.06 B
- Last Earnings Report Feb 19, 2025
- Price Reaction to Earnings Report 2.97%
- Enterprise Value $8.15 B
- P/E ratio -20.00
- Price/Sales ratio 1.50
- EV/Sales ratio 2.01
- Price/Book Value 1.73
- Revenue $4.05 B
- EBIT $0.43 B
- Net Income $-0.30 B
- Gross Profit $1.33 B
- Free Cash Flow $0.50 B
- EBIT Margin 10.51%
- Gross Margin 32.88%
- FCF Margin 12.39%
- Return on Equity -8.68%
- Equity Ratio 46.60%
- Debt/Equity Ratio 1.15
- 6-month Performance -34.54%
- 12-month Performance -48.47%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |